儿童脓毒性休克急性期内皮型转变反映风险与治疗反应变化
该多中心观察性队列研究纳入375例脓毒性休克患儿,在病程第1天和第3天检测100个内皮型分型基因,确定内皮型是否随时间改变及与结局的关系。第1天A型132例中56例(42%)第3天转为B型;第1天B型243例中77例(32%)第3天转为A型。第1天A型与死亡率增加相关,该风险受第3天内皮型修正;持续A型者使用糖皮质激素与死亡率增加相关。结论提示相当比例患儿急性期内皮型转变,不良结局风险和糖皮质激素反应随内皮型改变而变化,持续A型者结局最差。
要点
- 儿童脓毒性休克内皮型可在病程第1天至第3天发生转变:A型转B型42%(56/132),B型转A型32%(77/243)。
- 第1天A型与死亡率增加相关,但该风险受第3天内皮型修正。
- 持续A型者死亡风险最高,且糖皮质激素与死亡率增加相关。
- 内皮型分型基于100个反映适应性免疫和糖皮质激素受体信号通路的基因。
适用人群与场景
- 儿童脓毒性休克患者,来自多个儿科重症监护病房(PICU),包括现有和新入组参与者。
诊断标准与关键阈值
- 基于100个反映适应性免疫和糖皮质激素受体信号通路的基因将脓毒性休克分为A型和B型内皮型。
研究设计与关键结果
- 多中心观察性队列研究,纳入375例脓毒性休克患儿,在病程第1天和第3天检测100个内皮型分型基因。
- 第1天A型132例中56例(42%)第3天转为B型;第1天B型243例中77例(32%)第3天转为A型。
- 第1天A型与死亡率增加相关,该风险受第3天内皮型修正。
- 持续A型者使用糖皮质激素与死亡率增加相关。
- 采用多变量逻辑回归校正疾病严重程度、年龄和合并症负担。
证据类型、等级与局限
- 证据类型:观察性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,相当比例脓毒性休克患儿在急性期内皮型发生转变,不良结局风险和糖皮质激素反应随内皮型改变而变化。
- 作者认为,持续A型患者不良结局风险最高。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: We previously identified septic shock endotypes A and B based on 100 genes reflecting adaptive immunity and glucocorticoid receptor signaling. The endotypes differ with respect to outcome and corticosteroid responsiveness. We determined whether endotypes change during the initial 3 days of illness, and whether changes are associated with outcomes.
DESIGN: Observational cohort study including existing and newly enrolled participants.
SETTING: Multiple PICUs.
PATIENTS: Children with septic shock.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: We measured the 100 endotyping genes at day 1 and day 3 of illness in 375 patients. We determined if endotype assignment changes over time, and whether changing endotype is associated with corticosteroid response and outcomes. We used multivariable logistic regression to adjust for illness severity, age, and comorbidity burden. Among the 132 subjects assigned to endotype A on day 1, 56 (42%) transitioned to endotype B by day 3. Among 243 subjects assigned to endotype B on day 1, 77 (32%) transitioned to endotype A by day 3. Assignment to endotype A on day 1 was associated with increased odds of mortality. This risk was modified by the subsequent day 3 endotype assignment. Corticosteroids were associated with increased risk of mortality among subjects who persisted as endotype A.
CONCLUSIONS: A substantial proportion of children with septic shock transition endotypes during the acute phase of illness. The risk of poor outcome and the response to corticosteroids change with changes in endotype assignment. Patients persisting as endotype A are at highest risk of poor outcomes.
参考来源
- Wong HR, Cvijanovich NZ, Anas N, et al. Endotype Transitions During the Acute Phase of Pediatric Septic Shock Reflect Changing Risk and Treatment Response. Crit Care Med. 2018. PMID: 29252929. doi:10.1097/CCM.0000000000002932
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。